These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 30581033)
1. [Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe]. Chassain K; Croué A; Blanchard E; Leclerc-Mercier S; Fischer J; Martin L Ann Dermatol Venereol; 2019 Feb; 146(2):125-130. PubMed ID: 30581033 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous clinical remission of Nagashima-type palmoplantar keratoderma in a patient of Korean descent with a heterozygous SERPINB7 mutation. Thakker S; Owusu-Agyei M; Marchalik R; Kang JK Pediatr Dermatol; 2024; 41(2):369-371. PubMed ID: 38165066 [TBL] [Abstract][Full Text] [Related]
3. Nagashima-type palmoplantar keratosis in a Chinese Han population. Zhang J; Zhang G; Ni C; Cheng R; Liang J; Li M; Yao Z Mol Med Rep; 2016 Nov; 14(5):4049-4054. PubMed ID: 27666198 [TBL] [Abstract][Full Text] [Related]
4. Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population. Xiao T; Liu Y; Wang T; Ren J; Xia Y; Wang X J Dermatol; 2022 May; 49(5):539-544. PubMed ID: 35178744 [TBL] [Abstract][Full Text] [Related]
5. A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma. Brandt E; Harjama L; Elomaa O; Saarela J; Donner K; Lappalainen K; Kivirikko S; Ranki A; Kere J; Kettunen K; Hannula-Jouppi K J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):413-418. PubMed ID: 37684051 [TBL] [Abstract][Full Text] [Related]
6. Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients. Liu J; Chen Z; Hu L; Song Z; Mo R; Tsang LS; Liu Y; Huang X; Gong Z; Lin Z; Yang Y J Dermatol; 2023 Mar; 50(3):375-382. PubMed ID: 36317385 [TBL] [Abstract][Full Text] [Related]
7. Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis. Kubo A; Shiohama A; Sasaki T; Nakabayashi K; Kawasaki H; Atsugi T; Sato S; Shimizu A; Mikami S; Tanizaki H; Uchiyama M; Maeda T; Ito T; Sakabe J; Heike T; Okuyama T; Kosaki R; Kosaki K; Kudoh J; Hata K; Umezawa A; Tokura Y; Ishiko A; Niizeki H; Kabashima K; Mitsuhashi Y; Amagai M Am J Hum Genet; 2013 Nov; 93(5):945-56. PubMed ID: 24207119 [TBL] [Abstract][Full Text] [Related]
8. Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management. Huang C; Yang Y; Huang X; Zhou Z Biomed Res Int; 2021; 2021():8841994. PubMed ID: 33575348 [TBL] [Abstract][Full Text] [Related]
10. Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency. Kubo A J Invest Dermatol; 2014 Aug; 134(8):2076-2079. PubMed ID: 25029323 [TBL] [Abstract][Full Text] [Related]
11. SERPINB7 mutation causes Nagashima-type palmoplantar keratosis and its spatiotemporal expression in zebrafish. Lyu C; Zhang F; Liu T; Yu G; Ge K; Chen S; Sheng D; Sun Y Exp Dermatol; 2023 Jun; 32(6):766-776. PubMed ID: 36772997 [TBL] [Abstract][Full Text] [Related]
12. "Nagashima-type" keratosis as a novel entity in the palmoplantar keratoderma category. Kabashima K; Sakabe J; Yamada Y; Tokura Y Arch Dermatol; 2008 Mar; 144(3):375-9. PubMed ID: 18347294 [TBL] [Abstract][Full Text] [Related]
13. Novel nonsense mutation in SERPINB7 and the treatment of foot odor in a patient with Nagashima-type palmoplantar keratosis. Katsuno M; Shiohama A; Aoki S; Kitamura H; Sasaki T; Amagai M; Kubo A J Dermatol; 2017 Jul; 44(7):e146-e147. PubMed ID: 28439958 [No Abstract] [Full Text] [Related]
14. Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7. Songsantiphap C; Suwanwatana J; Ittiwut C; Asawanonda P; Rerknimitr P; Shotelersuk V Case Rep Dermatol; 2020; 12(3):241-248. PubMed ID: 33362511 [TBL] [Abstract][Full Text] [Related]
15. Updated allele frequencies of SERPINB7 founder mutations in Asian patients with Nagashima-type palmoplantar keratosis/keratoderma. Ito Y; Takeichi T; Ikeda K; Tanahashi K; Yoshikawa T; Murase Y; Muro Y; Kawakami Y; Nakamura Y; Matsuyama K; Muto J; Oiso N; Morizane S; Sugiura K; Suga Y; Seishima M; Kawada A; Ogi T; Akiyama M J Dermatol Sci; 2021 Aug; 103(2):116-119. PubMed ID: 34334259 [No Abstract] [Full Text] [Related]
16. A sporadic case of Nagashima-type palmoplantar keratosis caused by gene mutation in SERPINB7. Li CX; Zhang SQ; Wen J; Chen PJ; Liu QX; Han K; Zeng K; Zhang XB Clin Exp Dermatol; 2016 Oct; 41(7):811-3. PubMed ID: 27663160 [No Abstract] [Full Text] [Related]
17. Detection of SERPINB7 mutation can distinguish Nagashima-type palmoplantar keratoderma from other keratodermas with palmoplantar lesions. Hashimoto T; Teye K; Numata S; Suga Y; Hamada T; Ishii N Clin Exp Dermatol; 2017 Apr; 42(3):342-345. PubMed ID: 28211129 [No Abstract] [Full Text] [Related]
19. Progressive Nagashima-type palmoplantar keratosis in a Chinese patient with recurrent c.796C>T mutation in Qiu M; Zou XB Indian J Dermatol Venereol Leprol; 2017; 83(1):136. PubMed ID: 27506501 [No Abstract] [Full Text] [Related]
20. Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion. Cohen-Barak E; Azzam W; Koetsier JL; Danial-Farran N; Barcan M; Hriesh M; Khayat M; Edison N; Krausz J; Gafni-Amsalem C; Kubo A; Godsel LM; Ziv M; Allon-Shalev S Exp Dermatol; 2022 Feb; 31(2):214-222. PubMed ID: 34379845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]